ASHLEY MUELLER: Open Payments
NPI 1295248961 · CLAIRTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 54 payments from 17 companies in 2025. Trend: 2023 $230 · 2024 $609 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $360 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| PFIZER INC. | 4 | $82 |
| Amgen Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Dexcom, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
Products named: Wegovy, TRELEGY ELLIPTA, JARDIANCE, KEVEYIS, XIFAXAN, PREVNAR 20, Ozempic, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
